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Relationships between upper-limb functional limitation and self-reported
disability 3 months after stroke
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1
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Abstract—This study explored relationships between upperlimb (UL) functional limitations and self-reported disability in
stroke patients with relatively pure motor hemiparesis who were
enrolled in an acute rehabilitation treatment trial. All participants
were enrolled in the VECTORS (Very Early Constraint Treatment for Recovery from Stroke) study. VECTORS is a singlecenter pilot clinical trial of early application of constraintinduced movement therapy (CIMT). All 39 subjects who completed 90 days of VECTORS were included in this analysis.
Trained study personnel who were blinded to the treatment type
performed all evaluations. Data in this article examine relationships between assessments performed 90 days after stroke.
Functional limitation measures included the Action Research
Arm (ARA) test and Wolf Motor Function Test (WMFT), and
self-reported disability measures included the Functional Independence Measure (FIM) and Motor Activity Log (MAL) (by
telephone). Mean plus or minus standard deviation time from
stroke onset to randomization was 9.4 plus or minus 4.3
days, and median time to follow-up was 99 days (range 68–178).
Subjects with perfect or near-perfect scores on the ARA test or
WMFT reported residual disability on the FIM and MAL. Quality of movement on the WMFT (functional ability score) was not
strongly associated with self-reported frequency, and speed of
movement on the WMFT (timed score) was not associated with
self-reported frequency (MAL amount of use). In this early UL
intervention trial, we found that perceived disability measures
captured information that was not assessed by functional limitation and impairment scales. Our results indicate that excellent
motor recovery as measured by functional limitation and impairment scales did not equal restoration of everyday productive UL
use and speed of task completion did not translate to actual use.
Our results confirm the need for a measurement strategy that is
sensitive to change, assesses a broad performance range, and

detects meaningful clinical improvements in early rehabilitation
intervention trials.

Key words: activities of daily living, arm, cerebrovascular
accident, constraint therapy, functional limitation, hemiplegia,
motor skills, outcome assessment (healthcare), randomized
controlled trials, rehabilitation, upper limb.

INTRODUCTION
Persistent loss of upper-limb (UL) motor function is
found in 45 percent of all stroke survivors and contributes substantially to stroke-related disability [1]. Current
rehabilitation care focuses on return to independence in
basic and instrumental activities of daily living (ADL)
rather than on restoration of motor or sensory function.

Abbreviations: ADL = activities of daily living, AOU = amount
of use, ARA = Action Research Arm (test), CIMT = constraintinduced movement therapy, FIM = Functional Independence
Measure, MAL = Motor Activity Log, NIHSS = National Institutes of Health Stroke Scale, QOM = quality of movement, UL =
upper limb, VECTORS = Very Early Constraint Treatment for
Recovery from Stroke, WMFT = Wolf Motor Function Test.
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More recently, treatments are being proposed based on
animal and human data that describe how the brain reacts
to injury and how various training paradigms alter or
improve motor recovery. These treatments, including
functional electrical stimulation [2], constraint-induced
movement therapy (CIMT) [3–5], and robotic training
[6], are all employed with the explicit goal of improving
UL motor function. Trials of these treatments will require
researchers to use a practical, sensitive, and valid measurement strategy to determine to what extent any given
treatment is effective and whether one treatment may be
superior to another.
Underlying the proposed rehabilitation techniques is
the assumption that improvements in UL motor function
will lead to reduced disability and increased social participation. Consequently, studies of newer techniques often
use a functional limitation measure as the primary end
point and only secondarily assess disability and participation. Yet, the ultimate goal of any treatment is to promote
independence and productive activities. Improved UL
motor function may then be viewed as simply the means to
this ultimate goal.
Unfortunately, standardized measures of UL functional limitations may not adequately predict actual UL
use for ADL [1,7]. At this time, relationships between UL
motor performance as seen in the laboratory or clinic and
actual UL use in everyday life are poorly understood,
particularly in the context of acute rehabilitation treatment
trials. This presents a methodological challenge, since
improvement on a UL functional limitation measure cannot simply be assumed to translate to increased everyday
UL use, reduced disability, or improved participation.
While the relationships between UL functional limitation and associated disability have been extensively
explored in populations with subacute and chronic stroke
[8–9], they have not been fully examined in an acute
inpatient rehabilitation cohort. The population we have
chosen is of particular interest to investigators because
similar populations are used in clinical trials of early
motor interventions and in studies of early motor recovery. The first 90 days after stroke may be critical for the
application of behavioral interventions such as CIMT
because this may be when patients are most responsive to
such treatments. Several authors suggest that earlier rehabilitation interventions may be more effective [7,10–11].
Moreover, recent laboratory data suggest that rodents
respond best to motor interventions initiated within
14 days of injury and not at all if motor training is

delayed until 30 days after injury [12]. If earlier intervention proves effective, investigators will be challenged to
develop a measurement strategy that will be sensitive to
change, will assess a broad range of performance, and
will detect meaningful clinical improvements.
Our specific goal in this analysis was to evaluate the
relationships among the impairment, functional limitation, and perceived disability assessments used in the
Very Early Constraint Treatment for Recovery from
Stroke (VECTORS) clinical trial. The outcome of the
VECTORS trial and issues regarding CIMT will be discussed in other articles once the trial is completed and the
data are unblinded. At the time of this writing, the study
was ongoing.

METHODS
Subjects
All participants were enrolled in the VECTORS study.
The Washington University Human Studies Committee
approved the study, and all subjects provided informed consent before participation. VECTORS is a single-center pilot
clinical trial of the early application of CIMT; through VECTORS, necessary information is gathered for the design of a
definitive multicenter trial of CIMT administered in the
immediate poststroke period. Study and treatment procedures are described elsewhere [4]. VECTORS has a randomized, single-blind, controlled design. Subjects were
randomized to one of three groups: (1) 2 hours a day of conventional treatment, (2) 2 hours a day of shaping treatment
plus 6 hours of CIMT, or (3) 3 hours a day of shaping plus
CIMT 90 percent of waking hours.
Thirty-nine subjects who had completed 90 days of
VECTORS study participation were included in this
study. Inclusion and exclusion criteria were intended for
the selection of a group of hemiparetic subjects with
some residual voluntary UL control and limited sensory
or cognitive impairments who required inpatient rehabilitation and were unlikely to have complete, spontaneous recovery. Subjects were included if they had—
1. An ischemic or hemorrhagic stroke (with confirmatory
neuroimaging) within 28 days of admission to inpatient rehabilitation.
2. Persistent hemiparesis indicated by a score of 1 to 3
(where 1 designates a downward drift of the extended
arm, 2 designates some effort against gravity, and 3
designates no effort against gravity) on the motor arm
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item of the National Institutes of Health Stroke Scale
(NIHSS) [13].
3. Some proximal UL voluntary activity indicated by a
score of 3 or higher on the UL item of the Motor
Assessment Scale [14]; the ability to move the wrist
and fingers was not required.
4. Evidence of preserved cognitive function indicated by a
score of 0 or 1 on the consciousness and communication
items of the NIHSS, the ability to perform two-step commands, and a score of 8 or lower on the Short Blessed
Memory Orientation and Concentration Scale [15].
5. No UL injury or conditions that limited use before the
stroke.
Subjects were excluded if they—
1. Could not give informed consent.
2. Had clinically significant fluctuations in mental status
in the 72 hours before enrollment.
3. Were not independent before the index stroke as measured by scores <95 on the Barthel Index [16] or >1 on
the Modified Rankin Scale [17].
4. Had hemispatial neglect determined by more than
three errors on the Star Cancellation Test.
5. Had severe sensory loss determined by a score of 2 on
the sensory item of the NIHSS.
6. Were not expected to survive 1 year because of other
illnesses (e.g., cardiac disease, malignancy).
Procedures
Trained study personnel who were blinded to the
treatment type performed all evaluations. The data in this
article focus on the assessments performed at 90 days
after stroke onset. The 90-day time point was chosen as
the primary study end point because most acute stroke
intervention trials assess efficacy at 90 days after onset,
when the majority of stroke patients are at or near their
clinical plateau [18].
Measures
Functional Limitation Measures
Action Research Arm Test. The Action Research Arm
(ARA) test assesses functional limitations of the UL on the
affected side. It includes 19 items divided into four subscales: grasp, grip, pinch, and gross movement. Reliability
(interrater = 0.99, test-retest = 0.98), construct validity, and
predictive validity of the ARA test have been well established [19–20]. The ARA test uses ordinal scoring for each

subtest item. A score of 0 indicates no movement and a
score of 3 indicates normal movement. Item scores are
summed to create subtest and full-scale scores, with a
maximum score of 57 indicating normal performance.
Wolf Motor Function Test. The Wolf Motor Function
Test (WMFT) is a 17-item measure used for quantification
of UL functional limitations. It comprises 2 strength items
and 15 timed-task performance items. The task performance items begin with measuring simple proximal
movements and progress to more complex distal and
whole limb movements. The WMFT yields two scores: a
functional ability score, quantifying quality of performance, and a timed score, quantifying speed of performance in seconds. Reliability and validity of this test
have been well established [21–23]. In the VECTORS
study, the “key use” task was not collected, and the results
reported do not include this item.
Disability Measures
Motor Activity Log. The Motor Activity Log (MAL)
is a focal measure of self-perceived disability on tasks
requiring UL use. It is made up of a semistructured interview for assessing how much and how well patients use
their affected arm for ADL in the home over a specified
period of time [9]. Thirty specific ADL tasks are evaluated
with the use of a 6-point amount of use (AOU) scale and a
6-point quality of movement (QOM) scale. The tasks
include buttoning a shirt, brushing teeth, and using a key.
The MAL is administered independently to the patient and
a significant other or informant. Adequate interrater reliability and internal consistency have been reported.
Recently, the validity of a 14-item version has been demonstrated [24]. The self-report of study participants is reported
in this article.
Functional Independence Measure. The Functional Independence Measure (FIM) is an 18-item global
disability measure that incorporates concepts and items of
functional performance including ADL, bowel and bladder
function, social cognition, functional communication, and
functional mobility [25]. The FIM is scored on a 7-point
ordinal scale in which a score of 1 indicates dependence
and a score of 7 indicates independence. Reliability and
validity of the FIM have been established. Interrater reliability is 0.95 [26]. Construct validity for individuals surviving stroke is r = 0.65 (r = Pearson’s product moment
correlation coefficient) [27]. The FIM is endorsed by
the Agency for Healthcare. All evaluators in this study are
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certified by the Uniform Data System. In this study, the
FIM was scored by telephone interview and is therefore
considered a measure of self-perceived disability.
Impairment Measure
The NIHSS assesses cognitive, sensory, and motor
impairments to indicate overall stroke severity [13]. This
13-item test results in scores ranging from 0 (no deficit)
to 46 (severe deficit). Scores of 6 through 20 are widely
considered to be in the moderate range. The NIHSS
scores reported here were collected during the acute hospital service; this is the only measure reported in this article from the prerandomization assessment.
Analysis
We conducted statistical analyses using Statistical
Analysis System for Windows, version 9, SAS Institute
Inc, Cary, North Carolina. Descriptive statistics were calculated for all variables, and the normality of distribution
was examined for all study variables. We used contingency
tables and Student’s t-tests with Bonferroni corrections for
multiple comparisons to compare groups for normally distributed variables. Wilcoxon Signed Rank Tests were used
for comparisons between hemorrhagic and ischemic
strokes because of the unequal sample sizes. Pearson’s
product moment correlation coefficients (r) were computed
to examine relationships among the measures.
RESULTS
At the Barnes-Jewish Hospital in St. Louis, Missouri,
1,117 persons admitted to the acute neurology stroke service were screened for study eligibility through October
2004. Of these, 48 individuals gave their informed consent
and were randomized into the VECTORS study; 90-day
assessments were available on 39 subjects at the time of
this writing. Mean time ± standard deviation to randomization was 9.4 ± 4.3 days. Median time to follow-up was
99 days (range 68–178). Table 1 presents the demographic characteristics of the 39 subjects for whom the
data were available at the time of this study. Subjects were
enrolled based on the presence of a moderate degree of
UL motor dysfunction and the absence of severe sensory
or cognitive impairments. Study participants displayed a
wide range of overall stroke severity as measured by the
total NIHSS. Similarly, because no age criteria were used
for study eligibility, subjects ranged in age from 39 to
94 years. Sex, race/ethnicity, and stroke type (ischemic vs
hemorrhagic) represent the stroke patient population at

Table 1.
Characteristics of participants (N = 39).

Variable
Age (yr)
Admission NIHSS Score
NIHSS Upper-Limb
Score (Impaired)
Premorbid Barthel Score
Premorbid Modified
Rankin Index

Mean ± SD
64.54 ± 14.13
8.82 ± 4.84
1.82 ± 1.31

Range
39–94
2–21
0–4

99.47 ± 2.54
0.38 ± 0.66

85–100
0–2

Number (%)
Sex
Male
Female
Race/Ethnicity
Caucasian
African American
Other
Stroke Type
Ischemic
Hemorrhagic
Affected Side
Dominant
Nondominant

17 (44)
22 (56)
18 (46)
20 (51)
1 (3)
29 (74)
10 (26)
15 (38)
24 (62)

NIHSS = National Institute of Health Stroke Scale, SD = standard deviation.

Barnes-Jewish Hospital. Hemorrhagic stroke was defined
as having a primary hemorrhage; those subjects judged to
have hemorrhagic transformation of an ischemic infarct
were classified as having ischemic stroke. The majority of
subjects were affected on their nondominant side.
Group mean, median, and range on the functional limitation and disability measures at 90 days poststroke are provided in Table 2. A broad range of ARA test and WMFT
scores was found. For the ARA test, subjects in this sample
varied from the minimum score of 0 to the maximum
scores on each of the four ARA subtests and on the total.
For the WMFT functional ability score, no subject attained
the minimum score of 0 but 12/39 (31%) attained the maximum score of 5. On the disability measures, a broad distribution of scores was also seen with the FIM motor, FIM
UL, and MAL scores. In addition to the MAL QOM and
AOU scores, we chose to track the number of activities
attempted. This number could be important in reflecting
disability or changes in disability because scoring of the
MAL is based on activities that the subject attempted, leaving out those activities not attempted.
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Table 2.
Participants’ 90-day poststroke scores on upper-limb functional limitation and disability scales (N = 39).

Variable
Functional Limitation Measures
ARA Total
ARA Pinch
ARA Grasp
ARA Grip
ARA Gross Motor
WMFT Functional Ability Score
WMFT Time Scale
Disability Measures
FIM Motor
FIM Upper-Limb
MAL Quality of Movement
MAL Amount of Use
MAL Number of Activities Attempted

Maximum
Score

Mean ± Standard
Deviation

Median

Range

57
18
18
12
9
5
*

44.03 ± 16.14
12.34 ± 6.37
14.42 ± 5.50
9.82 ± 3.52
7.76 ± 2.36
4.14 ± 1.22
9.08 ± 16.25

51.5
15.5
18.0
12.0
9.0
4.68
3.75

0–57
0–18
0–18
0–12
0–9
0.64–5.00
1.27–78.41

91
35
5
5
30

81.00 ± 12.98
31.36 ± 4.83
3.67 ± 1.06
3.90 ± 1.16
19.75 ± 8.98

86.0
33.0
3.86
4.26
22.0

40–90
16–35
0.87–5.00
1.23–5.00
0–29

*WMFT maximum time allowable = 120 s; lower scores indicate better (faster) performance.
ARA = Action Research Arm (test), FIM = Functional Independence Measure, MAL = Motor Activity Log, WMFT = Wolf Motor Function Test.

We performed a series of t-tests to compare scores on
study measures by stroke subtype and affected side.
Comparisons of hemorrhagic and ischemic stroke subtypes with the use of the Wilcoxon test revealed no
significant differences on any measure. Similarly, comparison between dominant and nondominant affected
side showed no significant differences on any measure.
In evaluating possible ceiling effects, we found that
examination of individual scores revealed that 41 percent
(16/39) of participants achieved maximum scores on the
ARA test and 36 percent (14/39) of participants achieved
maximum scores on the WMFT functional ability scale. To
examine whether persons with full recovery on functional
limitation scales still had residual disability, we examined
FIM and MAL scores for subjects who had perfect or nearperfect scores on the ARA test and WMFT (Table 3). We
found that these subjects nonetheless reported residual disability. Moreover, evidence of persistent disability was
found in these persons with little measured functional limitation. Inspection of the mean FIM motor and UL scores
indicates that a majority of persons in this group are at or
near independence. The standard deviation values, however, indicate that measurable disability is present within
this group, where 62 percent scored 6 or less on at least
one FIM item. The MAL results are more striking. No
individual reported doing all 30 common tasks that make

up the MAL. More than half of the subjects reported not
taking off their shoes or putting a key in a door. Of the
MAL tasks performed in everyday life, all subjects with
little or no measured functional impairment reported some
decreased AOU and quality of performance on at least one
activity.
We computed correlation coefficients to examine the
relationships among the measures of functional limitation
and disability at 90 days. The total ARA test score was correlated with the FIM motor score (r = 0.47), MAL QOM
score (r = 0.61), and MAL number of activities attempted
(r = 0.60). The total ARA test was more highly correlated
with the WMFT time score (r = –0.65) and WMFT functional ability score (r = 0.95).
Correlations between the WMFT subscales and other
measures at 90 days were also computed. The WMFT
functional ability score was highly correlated with the
FIM motor score (r = 0.74), the MAL QOM score (r =
0.65), and the MAL number of activities attempted (r =
0.79). The correlation was lower for the MAL AOU
score (r = 0.40). The correlations for the WMFT time
score were FIM motor, r = –0.43; MAL QOM, r = –0.43;
and MAL number of activities attempted, r = –0.63. The
lowest correlation for the WMFT time scale was with the
MAL AOU, r = 0.007.
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Table 3.
Self-reported disability scores at 90 days poststroke in participants with little (near-perfect score) or no (perfect score) upper-limb functional
limitation.

Variable
ARA > 56 (n = 16)
FIM Motor
FIM Upper-Limb
MAL Quality of Measure
MAL Amount of Use
MAL Number of Activities Attempted
WMFT Functional Ability Score > 4.8 (n = 14)
FIM Motor
FIM Upper-Limb
MAL Quality of Measure
MAL Amount of Use
MAL Number of Activities Attempted

Maximum
Score

Mean ± Standard
Deviation

Range

% of Subjects at
Maximum Score

91
35
5
5
30

86.12 ± 11.02
33.37 ± 2.80
3.93 ± 1.19
4.28 ±1.04
22.00 ± 7.04

46–91
24–35
0.15–5.00
1.55–5.00
6–29

38
43
13
25
0

91
35
5
5
30

88.36 ± 3.18
34.29 ± 0.99
4.22 ± 0.66
4.17 ± 1.13
23.00 ± 4.82

81–91
31–35
3.2–5.0
1.55–5.00
14–29

43
57
14
36
0

ARA = Action Research Arm (test), FIM = Functional Independence Measure, MAL = Motor Activity Log, WMFT = Wolf Motor Function Test.

DISCUSSION
The proliferation of randomized controlled trials in
rehabilitation is forcing a critical examination of optimal
trial methodology. One important element in trial design
is the selection of appropriate end points. Currently, no
consensus exists on the appropriate end points for UL
motor intervention trials, and particularly for the inpatient rehabilitation phase of care. One step in developing
this consensus will be understanding the relationships
between impairment, functional limitation, and disability
measures. In short, we are examining the convergent and
divergent validity of these measures in this hemiparetic
population at 90 days after stroke [28]. The measures
reported in this article are among the most commonly
used assessments in rehabilitation clinical trials involving
ULs. One aim of VECTORS is the examination of candidate trial end points in preparation for a pivotal efficacy
trial of CIMT early after stroke onset, and we are reporting the first results from this yet-to-be-completed preliminary trial.
We found that subjects who met our inclusion criteria
demonstrated a surprisingly large amount of variability on
study measures. Study participants were not selected on the
basis of a total score on a clinical assessment, but rather a
series of specific UL motor impairments in the absence of
moderate or severe sensory or cognitive deficits. Study participants had to be sufficiently affected to justify 2 weeks of
inpatient rehabilitation, yet still have some residual volun-

tary UL motor function. Even on the baseline assessment of
overall stroke severity (NIHSS), scores varied from mild to
severe. Later, at the 90-day time point, the same patterns of
variability were evident in measures of functional limitation
and disability. At 90 days poststroke, subjects are at both
extremes on the functional limitation measures. Besides primary motor system dysfunction, the sources of this variability may include conditions such as apraxia, depression,
anosodiaphoria [29], and learned nonuse and are beyond the
purview of this phase II clinical trial. Another source of
variability may stem from differences in self-reported versus measured disability. The use of self-reported disability
measures, however, is widespread in most stroke acute
intervention trials such as the National Institute of Neurological Disorders and Stroke rt-PA (tissue plasminogen activator) trial [30].
Our results suggest that high scores on the ARA test
and the WMFT cannot be used as proxies for full recovery of everyday UL use on the affected side in early rehabilitation treatment trials. In our sample, subjects who
appeared fully recovered on these functional limitation
measures at 90 days still had some measurable disability.
In the group of participants with no detected functional
limitations, all reported somewhat diminished QOM on
the MAL tasks. In this sample of 39 individuals (selected
on criteria likely to be typical of future early UL intervention trials), these functional limitation measures did
not capture the full spectrum of motor dysfunction.
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These findings help to further describe the relationships between the measured components of UL motor
function and self-reported UL use in real life [8]. Understanding these relationships is important particularly in
rehabilitation trials that are designed to improve realworld (and not laboratory) performance. Improvements
in functional limitation did not necessarily lead to full
recovery of complex ADL. Correlations between the
ARA test, WMFT, and MAL scores suggest that, in this
sample, improved QOM was not sufficient for substantial
everyday UL use.
This study has some limitations. Our findings are relevant to a select group of stroke survivors without moderate or severe cognitive or sensory impairments who were
treated at a specific time after stroke and may not apply to
a broader sample of stroke patients. Yet, within a sample
such as ours, with minimal cognitive and sensory impairments, one might hypothesize that improvements in motor
function would have the greatest chance of lessening disability. Our inclusion criteria are likely to be typical of
those criteria used for studies of early UL recovery or
interventions that require some voluntary movement. The
disability scores are self-report scores and may not reflect
actual performance.
Others have noted that motor capacity does not necessarily predict actual use [31], and our data suggest that
this finding is also relevant in an early UL motor intervention trial. Our data indicate that for an early UL motor
intervention study requiring voluntary motor movement
after stroke, excellent performance on motor functional
limitation measures cannot be assumed to equal excellent
everyday UL productive use. We found that participants
at the ceiling of the ARA test and WMFT are not reporting full use of the affected UL in common productive
activities. Moreover, speed of movement, commonly
used to measure motor function, was not associated with
self-reported UL use in this sample.

CONCLUSIONS
Our results indicate that excellent motor recovery as
measured by functional limitation and impairment scales
did not equal restoration of everyday productive UL use
and speed of task completion did not translate to actual
use. Our results confirm the need for a measurement
strategy that is sensitive to change, assesses a broad range
of performance, and detects meaningful clinical improvements in early rehabilitation intervention trials.
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